The promise and perils of an Alzheimer disease vaccine: a video debate

J Neuroimmune Pharmacol. 2009 Mar;4(1):1-3. doi: 10.1007/s11481-008-9132-4.

Abstract

Alzheimer's disease (AD) is a critical health care problem that has considerable social and economic impact on society. Effective treatments have been elusive. One major causal factor for the disease is believed to be the deposition of amyloid fibrils in the brain, which ultimately leads to neurodegeneration and cognitive dysfunction. Based on the amyloid hypothesis of Alzheimer's disease, many therapies presently target the amyloid beta (Abeta) peptide, the monomeric protein fragment that assembles to form fibrils. This video article takes the form of a debate between Dr. Morgan and Dr. Landreth on the merits and drawbacks of an Alzheimer's disease vaccine. Click on Supplemental Material to watch the streaming video.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / immunology*
  • Alzheimer Disease / prevention & control*
  • Alzheimer Disease / psychology
  • Alzheimer Vaccines / adverse effects*
  • Alzheimer Vaccines / therapeutic use*
  • Amyloid beta-Peptides / immunology
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Cognition / physiology
  • Humans
  • Mice
  • Treatment Outcome

Substances

  • Alzheimer Vaccines
  • Amyloid beta-Peptides